DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Clinical trials for DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS trials appear
Sign up with your email to follow new studies for DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Rebooted' immune cells to fight crippling autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing an experimental treatment called QEL-005 in adults with two severe autoimmune conditions: difficult-to-treat rheumatoid arthritis and a serious form of systemic sclerosis. The treatment involves taking a patient's own immune cells, modifying them…
Matched conditions: DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Phase: PHASE1, PHASE2 • Sponsor: Quell Therapeutics Limited • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug trial targets hardened skin in rare autoimmune disease
Disease control Not yet recruitingThis study is testing an investigational drug called MTX-474 for people with diffuse cutaneous systemic sclerosis, a rare autoimmune disease that causes skin thickening and hardening. About 85 participants will be randomly assigned to receive either the drug or a placebo via an I…
Matched conditions: DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Phase: PHASE2 • Sponsor: Mediar Therapeutics • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC